| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Behrens M Kathleen is a Director at Sarepta Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 2 sells.
Estimated insider holdings value: $4.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2021 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 5,000 | $85.76 | $428,800.00 | -3.7% | -7.3% | -4.2% | |
| Sep 6, 2019 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 2,500 | $87.98 | $219,950.00 | +2.0% | - | - | |
| Oct 31, 2018 | SRPT Sarepta Therapeutics, Inc. | Director | Sale+OE | 10,000 | $131.71 | $1,317,100.00 | -7.9% | - | - | |
| Mar 16, 2016 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 75,000 | $16.28 | $1,220,708.50 | +127.1% | - | - |